Lantern Pharma(LTRN) - 2024 Q2 - Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Panna Sharma - President and CEO David Margrave - Chief Financial Officer Dr. Reggie Ewesuedo - Vice President, Clinical Development Conference Call Participants John Vandermosten - Zacks Research Operator Good afternoon. And welcome to our Second Quarter 2024 Earnings Call. As a reminder, this call is being recorded and all attendees are in a listen-only mode. We will open the call for question ...